SCHEMBL1816713

SCHEMBL1816713

COc1ccc(S(=O)(=O)N2CCSc3ccc(-c4ccc(C#N)s4)cc32)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.41
▸ CPT1A P50416 4/20 0.38
▸ CPT1B Q92523 3/20 0.38
▸ CPT2 P23786 2/20 0.38
▸ CNR1 P21554 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ RORC P51449 3/20 0.36
▸ NR1I2 O75469 1/20 0.36
▸ NR1H2 P55055 1/20 0.36
▸ NR1H3 Q13133 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PTGS2 P35354 6/20 0.34
▸ PTGS1 P23219 2/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ NAAA Q02083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818722 0.86 MAPT (0.42) MAPTCPT1ACPT1BCPT2CNR1
SCHEMBL1820944 0.86 RYR2 (0.42) CNR1CNR2RORCNR1I2NR1H2
SCHEMBL1820249 0.83 POLB (0.44) MAPTCPT1ACPT1BCPT2RORC
SCHEMBL1819673 0.81 RORC (0.49) CPT1ACPT1BCPT2CNR1CNR2
SCHEMBL1817520 0.81 RORC (0.47) MAPTCPT1ACPT1BCPT2CNR1
SCHEMBL12817920 0.81 CYP11B1 (0.40) CPT1ACPT1BCPT2CNR1CNR2
SCHEMBL12818521 0.80 CNR1 (0.37) CPT1ACPT1BCPT2CNR1CNR2
SCHEMBL12817913 0.80 CNR1 (0.37) CPT1ACPT1BCPT2CNR1CNR2
SCHEMBL12818475 0.79 PKM (0.38) MAPTCPT1ACPT1BCPT2CNR1
SCHEMBL12817972 0.79 GAA (0.40) CPT1ACPT1BCPT2CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback